TY - JOUR AU - Shariff, M. I. AU - Cox, I. J. AU - Gomaa, A. I. AU - Khan, S. A. AU - Gedroyc, W. AU - Taylor-Robinson, S. D. PY - 2009 DA - 2009// TI - Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics JO - Expert Rev Gastroenterol Hepatol. VL - 3 UR - https://doi.org/10.1586/egh.09.35 DO - 10.1586/egh.09.35 ID - Shariff2009 ER - TY - JOUR AU - Llovet, J. M. AU - Ricci, S. AU - Mazzaferro, V. AU - Hilgard, P. AU - Gane, E. AU - Blanc, J. -. F. PY - 2008 DA - 2008// TI - Sorafenib in advanced hepatocellular carcinoma JO - N Engl J Med. VL - 359 UR - https://doi.org/10.1056/NEJMoa0708857 DO - 10.1056/NEJMoa0708857 ID - Llovet2008 ER - TY - JOUR AU - Cheng, A. L. AU - Kang, Y. K. AU - Chen, Z. AU - Tsao, C. J. AU - Qin, S. AU - Kim, J. S. PY - 2009 DA - 2009// TI - Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial JO - Lancet Oncol. VL - 10 UR - https://doi.org/10.1016/S1470-2045(08)70285-7 DO - 10.1016/S1470-2045(08)70285-7 ID - Cheng2009 ER - TY - JOUR AU - So, B. J. AU - Bekaii-Saab, T. AU - Bloomston, M. A. AU - Patel, T. PY - 2008 DA - 2008// TI - Complete clinical response of metastatic hepatocellular carcinoma to sorafenib in a patient with hemochromatosis: a case report JO - J Hematol Oncol. VL - 1 UR - https://doi.org/10.1186/1756-8722-1-18 DO - 10.1186/1756-8722-1-18 ID - So2008 ER - TY - JOUR AU - Yeganeh, M. AU - Finn, R. S. AU - Saab, S. PY - 2009 DA - 2009// TI - Apparent remission of a solitary metastatic pulmonary lesion in a liver transplant recipient treated with sorafenib JO - Am J Transplant. VL - 9 UR - https://doi.org/10.1111/j.1600-6143.2009.02860.x DO - 10.1111/j.1600-6143.2009.02860.x ID - Yeganeh2009 ER - TY - JOUR AU - Irtan, S. AU - Chopin-Laly, X. AU - Ronot, M. AU - Faivre, S. AU - Paradis, V. AU - Belghiti, J. PY - 2011 DA - 2011// TI - Complete regression of locally advanced hepatocellular carcinoma induced by sorafenib allowing curative resection JO - Liver Int. VL - 31 UR - https://doi.org/10.1111/j.1478-3231.2010.02441.x DO - 10.1111/j.1478-3231.2010.02441.x ID - Irtan2011 ER - TY - JOUR AU - Wang, S. X. AU - Byrnes, A. AU - Verma, S. AU - Pancoast, J. R. AU - Rixe, O. PY - 2010 DA - 2010// TI - Complete remission of unresectable hepatocellular carcinoma treated with reduced dose of sorafenib: a case report JO - Target Oncol. VL - 5 UR - https://doi.org/10.1007/s11523-010-0133-x DO - 10.1007/s11523-010-0133-x ID - Wang2010 ER - TY - JOUR AU - Chelis, L. AU - Ntinos, N. AU - Souftas, V. AU - Deftereos, S. AU - Xenidis, N. AU - Chamalidou, E. PY - 2011 DA - 2011// TI - Complete response after sorafenib therapy for hepatocellular carcinoma in an HIV-HBV co infected patient: Possible synergy with HAART? A case report JO - Med Oncol. VL - Suppl 1 UR - https://doi.org/10.1007/s12032-010-9669-y DO - 10.1007/s12032-010-9669-y ID - Chelis2011 ER - TY - JOUR AU - Curtit, E. AU - Thiery-Vuillemin, A. AU - Nguyen, T. AU - Heyd, B. AU - Pivot, X. AU - Martino, V. PY - 2011 DA - 2011// TI - Complete histologic response induced by sorafenib in advanced hepatocellular carcinoma: a case report JO - J Clin Oncol. VL - 29 UR - https://doi.org/10.1200/JCO.2010.32.6785 DO - 10.1200/JCO.2010.32.6785 ID - Curtit2011 ER - TY - JOUR AU - Sacco, R. AU - Bargellini, I. AU - Gianluigi, G. AU - Bertini, M. AU - Bozzi, E. AU - Altomare, E. PY - 2011 DA - 2011// TI - Complete response for advanced liver cancer during sorafenib therapy: case report JO - BMC Gastroenterol. VL - 11 UR - https://doi.org/10.1186/1471-230X-11-4 DO - 10.1186/1471-230X-11-4 ID - Sacco2011 ER - TY - JOUR AU - Inuzuka, T. AU - Nishikawa, H. AU - Sekikawa, A. AU - Takeda, H. AU - Henmi, S. AU - Sakamoto, A. PY - 2011 DA - 2011// TI - Complete response of advanced hepatocellular carcinoma with multiple lung metastases treated with sorafenib: a case report JO - Oncology VL - Suppl 1 UR - https://doi.org/10.1159/000333279 DO - 10.1159/000333279 ID - Inuzuka2011 ER - TY - JOUR AU - Mizukami, H. AU - Kagawa, T. AU - Arase, Y. AU - Nakahara, F. AU - Tsuruya, K. AU - Anzai, K. PY - 2012 DA - 2012// TI - Complete response after short-term sorafenib treatment in a patient with lymph node metastasis of hepatocellular carcinoma JO - Case Rep Oncol. VL - 5 UR - https://doi.org/10.1159/000341259 DO - 10.1159/000341259 ID - Mizukami2012 ER - TY - JOUR AU - Lulla, P. D. AU - Brammer, J. E. AU - Bandeali, S. AU - Lynch, G. R. PY - 2013 DA - 2013// TI - Sustained complete remission of metastatic hepatocellular carcinoma with single agent sorafenib JO - J Gastrointest Cancer. VL - 44 UR - https://doi.org/10.1007/s12029-012-9438-6 DO - 10.1007/s12029-012-9438-6 ID - Lulla2013 ER - TY - JOUR AU - Kim, M. S. AU - Jin, Y. J. AU - Lee, J. W. AU - Lee, J. I. AU - Kim, Y. S. AU - Lee, S. Y. PY - 2013 DA - 2013// TI - Complete remission of advanced hepatocellular carcinoma by sorafenib: a case report JO - World J Gastrointest Oncol. VL - 5 ID - Kim2013 ER - TY - JOUR AU - Liu, L. AU - Cao, Y. AU - Chen, C. AU - Zhang, X. AU - McNabola, A. AU - Wilkie, D. PY - 2006 DA - 2006// TI - Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5 JO - Cancer Res. VL - 66 UR - https://doi.org/10.1158/0008-5472.CAN-06-1377 DO - 10.1158/0008-5472.CAN-06-1377 ID - Liu2006 ER - TY - JOUR AU - Yoshida, T. AU - Hisamoto, T. AU - Akiba, J. AU - Koga, H. AU - Nakamura, K. AU - Tokunaga, Y. PY - 2006 DA - 2006// TI - Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors JO - Oncogene. VL - 25 UR - https://doi.org/10.1038/sj.onc.1209635 DO - 10.1038/sj.onc.1209635 ID - Yoshida2006 ER - TY - JOUR AU - Novi, M. AU - Lauritano, E. C. AU - Piscaglia, A. C. AU - Barbaro, B. AU - Zocco, M. A. AU - Pompili, M. PY - 2009 DA - 2009// TI - Portal vein tumor thrombosis revascularization during sorafenib treatment for hepatocellular carcinoma JO - Am J Gastroenterol. VL - 104 UR - https://doi.org/10.1038/ajg.2009.140 DO - 10.1038/ajg.2009.140 ID - Novi2009 ER - TY - JOUR AU - Trevisani, F. AU - DIntino, P. E. AU - Morselli-Labate, A. M. AU - Mazzella, G. AU - Accogli, E. AU - Caraceni, P. PY - 2001 DA - 2001// TI - Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease:influence of HBsAg and anti-HCV status JO - J Hepatol VL - 34 UR - https://doi.org/10.1016/S0168-8278(00)00053-2 DO - 10.1016/S0168-8278(00)00053-2 ID - Trevisani2001 ER - TY - JOUR AU - Grünwald, V. AU - Heinzer, H. AU - Fiedler, W. PY - 2007 DA - 2007// TI - Managing side effects of angiogenesis inhibitors in renal cell carcinoma JO - Onkologie. VL - 30 UR - https://doi.org/10.1159/000107721 DO - 10.1159/000107721 ID - Grünwald2007 ER - TY - JOUR AU - Vincenzi, B. AU - Santini, D. AU - Russo, A. AU - Addeo, R. AU - Giuliani, F. AU - Montella, L. PY - 2010 DA - 2010// TI - Early skin toxicity as a predictive factor for tumor control in hepatocellular carcinoma patients treated with sorafenib JO - Oncologist. VL - 15 UR - https://doi.org/10.1634/theoncologist.2009-0143 DO - 10.1634/theoncologist.2009-0143 ID - Vincenzi2010 ER - TY - JOUR AU - Shao, Y. Y. AU - Lin, Z. Z. AU - Hsu, C. AU - Shen, Y. C. AU - Hsu, C. H. AU - Cheng, A. L. PY - 2010 DA - 2010// TI - Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma JO - Cancer. VL - 116 UR - https://doi.org/10.1002/cncr.25257 DO - 10.1002/cncr.25257 ID - Shao2010 ER -